ASTRAZENECA PHARMACEUTICALS

Jul 23, 08
	NEW STORY
08:00 ET	AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs
Jul 10, 08
07:45 ET	AstraZeneca Supports New PhRMA Code on Interactions with Healthcare Providers: Will Ensure Compliance to Benefit Patient Care
Jul 01, 08
18:28 ET	Summary Judgment Granted for SEROQUEL(R) Patent Litigation
Jun 04, 08
08:00 ET	AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
May 30, 08
07:00 ET	AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
May 22, 08
12:13 ET	AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
May 20, 08
13:11 ET	Study Analyzed SYMBICORT(R) in Children with Persistent Asthma
08:15 ET	New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
May 19, 08
07:00 ET	New Survey Reveals Hispanic-Americans Are Taking Steps to Better Understand and Manage GERD
May 14, 08
07:00 ET	FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
May 08, 08
08:00 ET	AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
May 05, 08
15:17 ET	New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
Apr 30, 08
08:00 ET	AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
Apr 17, 08
09:28 ET	Washington University in St. Louis and AstraZeneca Announce Alzheimer's Research Collaboration
Mar 18, 08
10:25 ET	Study Compares Bronchodilatory Effects of SYMBICORT(R) and Advair in Adults With Asthma
Mar 17, 08
10:16 ET	Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma
Mar 12, 08
09:00 ET	AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
Feb 29, 08
06:00 ET	AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
Feb 28, 08
09:21 ET	FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
Feb 21, 08
15:59 ET	AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
Jan 24, 08
09:17 ET	M. D. Anderson Cancer Center and AstraZeneca Form Alliance to Advance Understanding of Cancer-Related Neuropathic Pain
Jan 22, 08
12:02 ET	AstraZeneca Makes FORTUNE's 2008 '100 Best Companies to Work For' List for Third Time
Jan 02, 08
08:00 ET	AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
Dec 19, 07
09:00 ET	AstraZeneca and Banner Alzheimer's Institute Collaborate to Evaluate New Tool Targeting Alzheimer's Disease
Dec 14, 07
16:30 ET	Data Show ARIMIDEX(R) (Anastrozole) Continues To Be Superior to Tamoxifen in Helping Reduce the Risk of Recurrence in Patients With Early Breast Cancer
Dec 10, 07
12:34 ET	FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
Nov 30, 07
09:00 ET	AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
Nov 29, 07
08:00 ET	AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA
Nov 16, 07
07:00 ET	SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
Nov 12, 07
09:47 ET	AstraZeneca Appoints Kenneth L. Murtha as Regional Supply VP for the Americas
Nov 09, 07
07:00 ET	CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol
Nov 07, 07
11:00 ET	New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
Nov 06, 07
07:51 ET	AstraZeneca Announces NEXIUM(R)(esomeprazole magnesium) Savings Program for Purple Plus(TM) Members
Nov 05, 07
08:00 ET	New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
Nov 02, 07
21:30 ET	AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
Oct 25, 07
08:00 ET	National Survey Confirms Asthma Awareness 'Gap'
Oct 16, 07
08:25 ET	Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
Oct 10, 07
13:55 ET	AstraZeneca to Provide Free Medicines to Illinois' Largest Free Clinic
Oct 01, 07
12:30 ET	AstraZeneca Launches New Program to Support Facilities that Connect People to Needed Medical Care and Prescription Assistance
Sep 25, 07
14:05 ET	AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year
10:08 ET	Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
Sep 24, 07
09:00 ET	AstraZeneca and UT Southwestern Medical Center Collaborate to Combat Psychiatric Illness
Sep 20, 07
14:52 ET	Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Sep 18, 07
09:54 ET	AstraZeneca Launches New Virtual Fund-Raising Activity to Honor Breast Cancer Survivors
Sep 10, 07
09:42 ET	Back-to-School Campaign Motivates Children and Parents to Embrace 'Habits for Health'
Aug 07, 07
09:00 ET	Breast Cancer Survivors Carry Optimistic Outlook on Life, Yet Lack Critical Information about Reducing Recurrence
Jul 17, 07
09:09 ET	Medical Society of Delaware Announces Contribution From AstraZeneca to Continue Program to Increase Access to Health Insurance
Jun 25, 07
07:00 ET	AstraZeneca Announces SYMBICORT(R) is Now Available in the U.S.
Jun 06, 07
10:39 ET	AstraZeneca Extends Its Support to Greensburg, Kansas Area Residents After Devastating Tornado
May 24, 07
10:00 ET	American Cancer Society to Break Ground for AstraZeneca Hope Lodge in Philadelphia
May 22, 07
15:00 ET	New Study Analyses Confirm Once-Daily SEROQUEL XR(TM) Extended-Release Tablets as Effective Treatment for Schizophrenia
10:06 ET	AstraZeneca is Proud to Support the American Psychiatric Association International Career Development Awards to Promising Psychiatry Researchers
08:02 ET	New Studies Evaluating NEXIUM(R) In Pediatric GERD To Be Presented At Annual Digestive Disease Week Meeting
08:01 ET	New Research Examines Relationship Between GERD and Other Health Conditions
May 18, 07
08:00 ET	FDA Approves Astrazeneca's Once-Daily Seroquel XR(TM) Extended-Release Tablets for the Treatment of Schizophrenia
02:15 ET	FDA Approves Astrazeneca's Once-Daily Seroquel XR(TM) Extended-Release Tablets for the Treatment of Schizophrenia
May 09, 07
13:11 ET	AstraZeneca U.S. Honored By The National Business Group on Health As One of Best Employers for Healthy Lifestyles
May 07, 07
10:56 ET	AstraZeneca to Begin Construction for $100M Research Investment at R&D Boston; Expansion Solidifies Company's Commitment to Massachusetts as a Scientific and Biotech Hub
Apr 24, 07
08:00 ET	AstraZeneca Helps Expand Access to Healthcare for Uninsured Through New Statewide Initiative
Apr 19, 07
09:55 ET	AstraZeneca Addresses Lack of Diversity in Clinical Trials for Medicines
Feb 26, 07
09:01 ET	AstraZeneca Announces New Phase III Study of Vandetanib (ZACTIMA(R), ZD6474) in Patients With Advanced Lung Cancer
Jan 30, 07
09:57 ET	AstraZeneca and the National Alliance on Mental Illness (NAMI) Partner to Significantly Increase Number of Mental Illness Support Groups Nationwide
Jan 22, 07
08:30 ET	AstraZeneca Makes $100M Research Investment In Boston
Jan 10, 07
08:45 ET	AstraZeneca Reaccredited for Meeting Prestigious 'CEO Cancer Gold Standard'(TM)
Jan 08, 07
10:31 ET	AstraZeneca Joins the American Heart Association to Promote Workplace Wellness
Dec 14, 06
11:49 ET	Data Presented Today Show ARIMIDEX(R) Combined With Herceptin(R) Extended Progression-Free Survival in Patients With Advanced HER-2-Positive and Hormone Receptor-Positive Breast Cancer
Dec 06, 06
08:00 ET	My Medicare Matters(TM) Campaign to Award Grants for New Initiatives to Reach Low-Income Seniors
Dec 01, 06
08:28 ET	AstraZeneca's Statement on the Cost-Effectiveness Findings of the Clinical Antipsychotic Trials of Intervention Effectiveness-Schizophrenia (CATIE-SZ)
Nov 21, 06
17:30 ET	AstraZeneca Announces Distribution Agreement With Par Pharmaceutical for an Authorized Generic Version of TOPROL-XL(R)
Nov 13, 06
11:37 ET	Approved Asthma Therapy SYMBICORT Improves Lung Function Safely and Effectively
11:20 ET	Once- or Twice-Daily Treatment With PULMICORT RESPULES(R) (budesonide inhalation suspension) Significantly Increased Percentage of Days Asthma Is Controlled
11:13 ET	New Studies Reveal What Caregivers See as Key Issues to Facilitate Better Asthma Treatment
Nov 09, 06
10:28 ET	AstraZeneca Announces New Program that Offers Significant and Convenient Savings for Medicare Part D Enrollees
09:00 ET	Childhood Acid Reflux Disease Poses Challenges for Many Families, National Survey Reveals
Nov 06, 06
10:45 ET	Science Survey Ranks AstraZeneca as Top Employer for Fifth Consecutive Year
Nov 02, 06
06:00 ET	AstraZeneca Helps More People Afford Its Medicines
Nov 01, 06
09:15 ET	AstraZeneca Appoints Howard Hutchinson as Chief Medical Officer
Oct 27, 06
09:45 ET	AstraZeneca Honors 2006 'Excellence in Chemistry' Award Recipients
Oct 24, 06
09:05 ET	FDA Approves New Formulation for NEXIUM
Oct 20, 06
15:15 ET	FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression Treatment
Oct 12, 06
16:21 ET	FDA Approves NEXIUM for the Treatment of Zollinger-Ellison Syndrome
Sep 29, 06
10:33 ET	AstraZeneca Joins the Congressional Black Caucus Foundation and Congressman Jesse Jackson, Jr. in the Fight Against Obesity
Sep 27, 06
08:30 ET	AstraZeneca Opens Its First Clinical Pharmacology Unit in the U.S. at the University of Pennsylvania's Penn Presbyterian Medical Center
Sep 25, 06
09:00 ET	AstraZeneca Named Among '100 Best Companies' for Working Mothers for Fifth Consecutive Year
Aug 01, 06
08:00 ET	Aromatase Inhibitors Declared Superior to Tamoxifen in the Adjuvant Treatment of Early Breast Cancer
Jul 25, 06
09:01 ET	NEXIUM(R) Maintains Healing of Erosive Esophagitis Better Than Lansoprazole, New Study Shows
Jul 18, 06
08:30 ET	AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
Jun 22, 06
14:03 ET	New Data Shows CRESTOR(R) Helped African American, Hispanic American and South Asian American Patients Significantly Lower LDL-C and Achieve Cholesterol Goals
Jun 04, 06
15:15 ET	Results of Phase II Studies Measure Progression Free Survival for ZACTIMA(TM) (ZD6474) in Lung Cancer
Jun 03, 06
08:00 ET	New Data Show That Five Years of Treatment With Arimidex(R) (anastrozole) Did Not Cause Osteoporosis in Early Breast Cancer Patients With Normal Bone Mineral Density at Outset
May 24, 06
09:10 ET	Studies Showed Lack of Asthma Control Leads to Increased Emergency Room Visits and Hospitalization
May 23, 06
15:00 ET	Second Investigational Study of SEROQUEL(R) in the Treatment of Depressive Episodes Associated with Bipolar Disorder Confirms Previous Findings
07:00 ET	American Psychiatric Association and AstraZeneca Award Unique International Career Development Prizes to Top Psychiatry Researchers
May 22, 06
15:08 ET	New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
12:06 ET	Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome
09:51 ET	New Study Shows Erosive Esophagitis Healing Linked to Gastric Acid Control
May 19, 06
13:00 ET	AstraZeneca Launches Awareness Campaign to Support Proper Medication Dispensing
May 15, 06
09:46 ET	CRESTOR Helped More Patients Reach Goal in MERCURY II Study
May 11, 06
09:05 ET	AstraZeneca Extends Its Support to New Orleans Community:
May 10, 06
18:17 ET	AstraZeneca Foundation to Expand Patient Assistance Program
May 04, 06
09:21 ET	Combined Use of ATACAND(R) (candesartan cilexetil) and ACE Inhibitor Improves Heart Failure Outcomes More Than ACE Inhibitor Alone
May 01, 06
09:24 ET	FDA Approves Use of NEXIUM(R) in Children Ages 12 to 17 For Short-Term Treatment of GERD
Apr 20, 06
08:30 ET	Novel Study Published in New England Journal of Medicine Evaluates Effects of ATACAND(R) (candesartan cilexetil) in Patients With Prehypertension
Apr 18, 06
09:00 ET	AstraZeneca Foundation Patient Assistance Program Expands Eligibility for People With Medicare
Mar 30, 06
08:03 ET	AstraZeneca Helps Rebuild Hurricane-Damaged New Orleans Health Care Network
Mar 24, 06
08:00 ET	First-Ever Large-Scale Prospective Study in Hispanic Patients With Elevated Cholesterol Demonstrates Significant Cholesterol Reductions With CRESTOR(R)
Mar 22, 06
09:37 ET	NEXIUM(R) Shown to Reduce Gastric Ulcers in At-Risk Patients Using Long-Term NSAIDs
Mar 17, 06
11:50 ET	AstraZeneca and University of Pennsylvania School of Medicine to Collaborate on Research
Mar 14, 06
10:00 ET	Novel TROPHY Study Is First to Evaluate Effects of Pharmacological Intervention in Patients With Prehypertension
03:30 ET	Headline Results From CHANT Safety and Tolerability Study In Intracerebral Hemorrhage (ICH) Show NXY-059 Achieved Key Endpoints
Mar 13, 06
14:01 ET	New Data Presented at American College of Cardiology Meeting Compares the AstraZeneca Investigational Drug AZD6140 to Clopidogrel for Inhibition of Platelet Aggregation
Mar 08, 06
14:14 ET	AstraZeneca Commences Patent Infringement Litigation Against IVAX
Mar 07, 06
09:45 ET	Study Shows Asthma Exacerbations Have Not Substantially Declined Over Time
Feb 28, 06
12:12 ET	AstraZeneca Pledges Support for Arkansas Governor's Healthy America Initiative
Feb 17, 06
17:30 ET	Economic Impact of Acute Ischemic Stroke Highlighted in New Study Results at International Stroke Congress (ISC)
Feb 16, 06
09:17 ET	AstraZeneca U.S. Donates $500,000 to United Way of Delaware; Gift Will Support United Way's 'Healthy Delawareans Fund'
Feb 08, 06
17:02 ET	New England Journal of Medicine Publishes NXY-059 Study, the First International Study of a Neuroprotectant to Show Reduced Disability Following Acute Ischemic Stroke
Feb 02, 06
09:12 ET	FDA Grants Fast Track Designation for the Investigation of ZACTIMA(TM) (ZD6474) for the Treatment of Thyroid Cancer
Jan 23, 06
09:00 ET	Meek, CBCF to Launch Health Initiative in Miami
Jan 12, 06
09:02 ET	AstraZeneca and M. D. Anderson Cancer Center Form Umbrella Scientific Collaboration Agreements
Jan 03, 06
09:51 ET	AstraZeneca Submits sNDA for SEROQUEL(R) for Bipolar Depression Treatment
Dec 30, 05
11:30 ET	AstraZeneca Submits sNDA for SEROQUEL(R) for Bipolar Depression Treatment
Dec 10, 05
09:01 ET	Analysis Demonstrates Time to Response With FASLODEX(R) (Fulvestrant) Injection Comparable to Anastrozole for Postmenopausal Women With Metastatic Breast Cancer
Dec 09, 05
12:15 ET	ARIMIDEX(R) (anastrozole) Featured in Studies Evaluating Impact of Switching on Survival in Adjuvant Treatment of Early Breast Cancer
Nov 22, 05
11:10 ET	AstraZeneca Supports New My Medicare Matters Education Campaign
Nov 18, 05
09:59 ET	New Esomeprazole Magnesium Data in Non-cardiac Chest Pain
Nov 17, 05
14:33 ET	AstraZeneca Provides Additional Support to Hurricane Victims
Nov 16, 05
12:50 ET	Preliminary Results of Ongoing Phase II Study With ZACTIMA(TM) (ZD6474) in a Rare Form of Thyroid Cancer
Nov 15, 05
11:01 ET	New Phase IIb Data for AZD6140 Presented at American Heart Association Meeting
10:52 ET	New Data Examines Effects of CRESTOR(R) Alone or in Combination with Another Therapy in High Risk Patients with Very High Cholesterol
Nov 10, 05
08:31 ET	Review Article Indicated That Optimal Device Choice for Pediatric Asthma Drug Delivery Is the One Patients Prefer
Nov 08, 05
08:32 ET	New Study Indicated the Long-Term Use of PULMICORT RESPULES Is Well-Tolerated in Children with Severe Asthma
Nov 03, 05
09:14 ET	New Survey Shows Most Patients Being Treated for High Cholesterol Don't Know Their Goal
Nov 01, 05
10:56 ET	AstraZeneca Submits New Drug Application for TOPROL-XL(R)(metoprolol succinate)/Hydrochlorothiazide Combination Tablets for the Management of Hypertension
08:30 ET	AstraZeneca Proposes Mandatory FDA Review of All Pharmaceutical Direct-To-Consumer Advertising
Oct 31, 05
09:30 ET	AstraZeneca's SEROQUEL Named 'Product of the Year' by National Business & Disability Council
09:11 ET	FDA Grants AstraZeneca Orphan-Drug Designation for ZACTIMA (ZD6474) Being Investigated for the Treatment of Thyroid Cancer
Oct 11, 05
16:07 ET	New Analysis of CHARM Program Published in JAMA Evaluates Effect of ATACAND(R) (candesartan cilexetil) on Risk of Heart Attacks and Cardiovascular Mortality in Heart Failure Patients
Oct 03, 05
17:38 ET	Science Survey Ranks AstraZeneca as Top Employer for Fourth Consecutive Year
07:43 ET	New AstraZeneca Disease Awareness Campaign is First to Target Issue of Breast Cancer Recurrence
Sep 30, 05
14:12 ET	TOPROL-XL(R) (metoprolol succinate) US Patent Litigation
Sep 26, 05
09:00 ET	AstraZeneca Joins the Congressional Black Caucus Foundation in the Fight Against Obesity
Sep 23, 05
10:47 ET	AstraZeneca Submits New Drug Application (NDA) to FDA for SYMBICORT(R) (budesonide/formoterol) for the Maintenance Treatment of Asthma
Sep 19, 05
12:05 ET	ARIMIDEX(R) (anastrozole) Gains Full FDA Approval for Adjuvant Treatment of Hormone Receptor-Positive Early Breast Cancer in Postmenopausal Women
11:31 ET	NIMH-Funded Study Examines the Use of Antipsychotic Medications for the Treatment of Schizophrenia
Sep 15, 05
09:30 ET	AstraZeneca Appoints Tony Zook as Executive Vice President for North America
Sep 13, 05
11:14 ET	AstraZeneca to Provide Up to $5 Million in Free Medicine for Hurricane Katrina Relief
Sep 12, 05
07:29 ET	AstraZeneca Recognized for Fourth Consecutive Year as One of the Nation's '100 Best Companies for Working Mothers' By Working Mother Magazine
Sep 06, 05
09:10 ET	CHARM Program Evaluates Effects of ATACAND(R) (candesartan cilexetil) on the Development of Diabetes in Patients With Heart Failure
Sep 01, 05
13:23 ET	AstraZeneca Pledges More Than $1 Million in Contributions and Medicine to Victims of Hurricane Katrina
Aug 02, 05
15:31 ET	AstraZeneca Signs on to PhRMA Guidelines as Part of the Company's Ongoing Commitment to Responsible Direct-to-Consumer Advertising
Jul 06, 05
10:00 ET	New Phase II Data for AstraZeneca Compound ZACTIMA(TM) (ZD6474) Presented at the World Conference on Lung Cancer - Phase III Trials to Begin in the Fall
Jul 01, 05
08:00 ET	Newly Published Study Investigates SEROQUEL(R) as Monotherapy Treatment for Bipolar Disorder
Jun 23, 05
08:00 ET	AstraZeneca Presents New Data for Use of ZOMIG(R) (zolmitriptan) Nasal Spray in Adolescents at the American Headache Society Annual Meeting
Jun 17, 05
10:29 ET	AstraZeneca Announces US Label Change for IRESSA(R) (gefitinib) and New Distribution Program
Jun 13, 05
09:07 ET	Phase II Trial of GALIDA(TM) (tesaglitazar) Evaluates Glucose and Lipid Abnormalities in Type 2 Diabetes Patients
Jun 11, 05
12:30 ET	Phase II Trial of GALIDA(TM) (tesaglitazar) Evaluates Glucose and Lipid Abnormalities in Type 2 Diabetes Patients
May 26, 05
09:52 ET	FDA Approves MERREM(R) I.V. (Meropenem for Injection) for Complicated Skin and Skin Structure Infections
May 24, 05
12:00 ET	Data Further Examines SEROQUEL(R) (quetiapine fumarate) Treatment for Bipolar Depression
11:21 ET	Study Showed Adherence to PULMICORT RESPULES(R) Results in Fewer ER Visits and Hospitalizations in Asthmatic Children
07:01 ET	Top Psychiatry Researchers Honored with International Career Development Award
May 23, 05
20:32 ET	CRESTOR Safe and Effective When Used According to Prescribing Information
15:00 ET	Cognitive Function and Compliance With SEROQUEL(R) (quetiapine fumarate) Examined in Separate Studies in Patients With Schizophrenia
May 19, 05
10:14 ET	FDA Approves AstraZeneca's ATACAND(R) (candesartan cilexetil) for Use With an ACE Inhibitor in the Treatment of Heart Failure
May 16, 05
16:24 ET	New Study Reports Treatment with TOPROL-XL(R) (metoprolol succinate) Extended-Release Tablets for Hypertensive Children
09:40 ET	Study Compares Stomach Acid Control of Three Proton Pump Inhibitors in Chronic NSAID Users
08:02 ET	Geisinger Health System and AstraZeneca Announce Joint E-Health Initiative to Reduce Cardiovascular Disease and Improve Patient Care
May 12, 05
08:30 ET	Clinical Trials Indicate NEXIUM(R) Can Reduce Upper GI Symptoms in Patients Using NSAIDs
Apr 24, 05
16:00 ET	New Study on Effects of CRESTOR on Carotid Atherosclerosis Presented at European Atherosclerosis Society Congress
14:00 ET	New Data Demonstrates the Efficacy of CRESTOR(R) Compared to Other Leading Statins in Treating High-Risk Patient Populations For Elevated Cholesterol
Apr 05, 05
07:30 ET	AstraZeneca Strengthens Commitment to Provide Free and Low-Cost Medicines to Patients in Need Through New Industry Initiative
Apr 01, 05
09:28 ET	FDA Approves Intravenous Formulation for NEXIUM(R)
Mar 21, 05
08:44 ET	Study Indicated That Early Use of Nebulized Inhaled Corticosteroid Led to Fewer Hospitalizations for Young Children With Asthma
08:40 ET	Study Shows Earlier Use of Budesonide Reduced the Risk of Severe Asthma Related Events by 40% in Children
Mar 14, 05
15:50 ET	FDA Rejects Public Citizen's Petition for AstraZeneca's CRESTOR(R)
Mar 08, 05
16:42 ET	AstraZeneca Presents New Data Demonstrating CRESTOR(R) Reduced C-Reactive Protein Levels in African-American Patients
Mar 05, 05
19:16 ET	Study Examines SEROQUEL and the Risk of Cerebrovascular Adverse Events in Elderly Patients with Dementia
Mar 02, 05
14:16 ET	Labeling Revision for CRESTOR(R) Approved By FDA
Feb 23, 05
09:03 ET	FDA Approves AstraZeneca's ATACAND(R) (candesartan cilexetil) for the Treatment of Heart Failure
Feb 01, 05
12:10 ET	AstraZeneca Statement Regarding IRESSA(R) (gefitinib) Presentation at March FDA Advisory Board Meeting
Dec 27, 04
08:25 ET	Council Recommends Approval of CRESTOR in Japan
Dec 11, 04
08:00 ET	New Data Reported on FASLODEX(R) (Fulvestrant) Injection in Postmenopausal Women With Metastatic Breast Cancer Following Progression on Aromatase Inhibitor Therapy
Dec 08, 04
10:55 ET	New 5-Year Data Reported Comparing ARIMIDEX(R) (anastrozole) to Tamoxifen in the Treatment of Early Breast Cancer
Nov 29, 04
09:44 ET	NEXIUM Receives FDA Approval for Reduced Risk of Stomach Ulcer Development Among NSAID Users
09:21 ET	`Science' Survey Ranks AstraZeneca as Top Employer for Third Consecutive Year
Nov 18, 04
15:12 ET	AstraZeneca Reconfirms the Safety and Efficacy Benefits of CRESTOR(R)
Nov 15, 04
10:44 ET	New Study Shows Patients Experience Asthma Variability, Despite Strict Adherence to Treatment Guidelines
Nov 10, 04
07:00 ET	AstraZeneca CEO Speaks About Value of Medicines to Patients and Society Being at The Core of The Company's Commitment to Corporate Responsibility
Oct 08, 04
14:37 ET	AstraZeneca Receives Action Letter From FDA for EXANTA(R) (ximelagatran)
Sep 27, 04
10:13 ET	`Stroke Matters' Stroke Survey Launched Today
Sep 24, 04
08:28 ET	Working Mother Magazine Honors AstraZeneca As One of the '100 Best Companies for Working Mothers' in the Nation
Sep 16, 04
20:44 ET	AstraZeneca Files Suit Against KV Pharmaceutical Company for Patent Infringement
13:54 ET	AstraZeneca Names Les Paul, M.D., M.S. Vice President, Medical Affairs
Sep 13, 04
09:08 ET	AstraZeneca Launches New Clinical Trial for Non-Small-Cell Lung Cancer
Sep 10, 04
19:41 ET	FDA Advisory Committee Recommends Further Data to Support Approval of AstraZeneca's Oral Anticoagulant Exanta(R)
Sep 06, 04
06:30 ET	AstraZeneca Presents New Data for Crestor(R) in Patients With Metabolic Syndrome at EASD
Aug 26, 04
14:43 ET	AstraZeneca Names Two New Leaders to U.S. Government, Policy, and Managed Markets Group
10:49 ET	RHINOCORT AQUA(R) (budesonide) First and Only Intranasal Corticosteroid in U.S. to Receive FDA Pregnancy Category B Rating for Allergic Rhinitis
Aug 12, 04
08:03 ET	AstraZeneca's CRESTOR(R) Celebrates One-Year Anniversary of U.S. Approval
Aug 03, 04
10:34 ET	AstraZeneca Says Public Citizen Makes Irresponsible and Inaccurate Claims
Aug 02, 04
12:05 ET	AstraZeneca Submits sNDA for MERREM(R) I.V. (meropenem for injection) to Treat Complicated Skin and Skin Structure Infections
08:49 ET	World-Record Holder Mark Spitz Expresses Health Issues He Faced While Achieving Olympic Dreams
Jul 23, 04
08:37 ET	FDA Approves New Labeling for AstraZeneca's SEROQUEL to Include 12-Week Data in Treatment of Mania Associated With Bipolar Disorder
Jul 22, 04
17:29 ET	AstraZeneca Files Suit Against Andrx for Patent Infringement
08:48 ET	Study Examines SEROQUEL for the Treatment of Agitation in Elderly Patients with Dementia
Jul 21, 04
18:50 ET	AstraZeneca Urges FDA to Dismiss Public Citizen Petition on CRESTOR(R)
Jul 01, 04
08:30 ET	AstraZeneca Submits sNDA for ATACAND(R) to Treat Patients with Chronic Heart Failure
Jun 06, 04
15:14 ET	Final Results For IRESSA(R) (gefitinib) Tablets Reported From Compassionate Use Program in Non-Small-Cell Lung Cancer Patients
Jun 05, 04
09:20 ET	New IRESSA(R) (Gefitinib) Data Presented in Bronchioalveolar Lung Cancer
Jun 04, 04
08:02 ET	AstraZeneca Examines Impact of Cardiovascular Disease on Type 2 Diabetes at American Diabetes Association Annual Meeting
Jun 01, 04
10:03 ET	New Data on AstraZeneca Oncology Products to be Presented at Annual American Society of Clinical Oncology (ASCO) Meeting
08:56 ET	Data on SEROQUEL Published in `Bipolar Disorders'
May 27, 04
09:55 ET	MassMedLine Hosts the First in a Series of Workshops to Teach Seniors About Medicare Drug Discount Card and Benefit Program
May 25, 04
16:29 ET	AstraZeneca Names Three New Leaders to U.S. Executive Team
08:15 ET	New Study Shows That Asthma Variability Still Exists Despite Strict Adherence to National Management Guidelines
May 24, 04
08:23 ET	New Study Shows Asthma Drug Significantly Reduced Children's Emergency Room Visits
May 19, 04
10:23 ET	AstraZeneca Confirms Safety and Efficacy of CRESTOR; Company Responds to `Public Citizen'
May 17, 04
13:43 ET	Medicaid Experts Debate Future of Medicaid During Robert Wood Johnson Foundation's `Cover the Uninsured Week'
May 07, 04
08:08 ET	Studies Examine Remission with SEROQUEL Monotherapy for the Treatment of Bipolar Mania
May 05, 04
14:50 ET	New Study Examines SEROQUEL Treatment for Depressive Episodes Associated with Bipolar Disorder
09:35 ET	AstraZeneca and Medical Experts from Six Leading Institutions Launch www.AFAdvisor.org for National Stroke Awareness Month
09:30 ET	New National Survey from Alliance of Aging Research Indicates Lack of Public Awareness about Strokes Related to Atrial Fibrillation (AF)
May 04, 04
08:07 ET	Rising Young Psychiatry Researchers Receive Prestigious International Award
May 03, 04
16:09 ET	Humana and AstraZeneca Join Forces to Improve Cholesterol-Lowering Drug Compliance
09:42 ET	Survey Shows Less Than Half of African-American Parents in Chicago Are Aware of Triggers, Warning Signs of Childhood Asthma
09:41 ET	Survey Shows Less Than One-Third of African-American Parents in Washington, D.C. Know About the Triggers and Warning Signs of Childhood Asthma
09:24 ET	Survey Shows Less Than Half of African-American Parents in Philadelphia Know About the Triggers and Warning Signs of Childhood Asthma
09:23 ET	Survey Shows Less Than Half of African-American Parents in Atlanta Are Aware of Triggers, Warning Signs of Childhood Asthma
Apr 20, 04
08:03 ET	AstraZeneca Strengthens Research & Development Capabilities in the United States Through Considerable Investment in Wilmington, Delaware
Apr 19, 04
15:11 ET	AstraZeneca No. 1 on DiversityInc List of Top 10 Companies for Executive Women; Named One of the 20 Noteworthy Companies for Diversity
15:11 ET	AstraZeneca `Rising Star' Lori Kreamer to be Honored at 2004 HBA `Woman of the Year' Luncheon
Apr 06, 04
08:30 ET	AstraZeneca Files Suit Against Eon Labs for Patent Infringement
Mar 26, 04
08:02 ET	AstraZeneca Presents New Data on Oncology Pipeline Products
Mar 12, 04
06:01 ET	MassMedLine and AstraZeneca Collaborate to Help Seniors Understand and Access Prescription Drug Coverage and Assistance Options
Mar 09, 04
14:00 ET	New Data Showed Results of AstraZeneca's ATACAND in Broad Spectrum of Patients With Chronic Heart Failure
Mar 08, 04
11:01 ET	New Data for AstraZeneca's CRESTOR(R) in Patients With Metabolic Syndrome Presented at American College of Cardiology Scientific Session
11:00 ET	New Analysis of NHANES Data Demonstrates High Prevalence of Elevated C-Reactive Protein
Mar 03, 04
13:00 ET	PGA TOUR and AstraZeneca's CRESTOR(R) Launch Multi-Year Partnership, Introduce Season-Long CRESTOR(R) Charity Challenge
Feb 05, 04
13:14 ET	AstraZeneca Files Suit Against Andrx for Patent Infringement
Feb 02, 04
09:03 ET	IRESSA(R) (gefitinib) Added to American Society of Clinical Oncology (ASCO) Clinical Practice Guidelines
Jan 12, 04
16:23 ET	FDA Approves AstraZeneca's SEROQUEL(R) (quetiapine fumarate) Tablets for Treatment of Acute Mania Associated With Bipolar Disorder
Jan 08, 04
09:25 ET	Phase II Trial Data for IRESSA(R) (gefitinib) in Recurrent Brain Cancer
09:03 ET	R&D Directions Names AstraZeneca's Pipeline `The Best of the Best'
Dec 29, 03
14:05 ET	AstraZeneca Debuts on FORTUNE Magazine's `100 Best Companies to Work For' List
Dec 23, 03
08:29 ET	AstraZeneca Submits New Drug Application (NDA) for Investigational EXANTA(R) (ximelagatran) as First New Oral Anticoagulant in Over 50 Years
Dec 17, 03
10:01 ET	First Head-to-Head Study of All Five Currently Available Branded PPIs Published
Dec 11, 03
17:05 ET	AstraZeneca Prilosec(R) Patents Upheld by Federal Appeals Court
Dec 06, 03
17:01 ET	Phase III Study Reports the Results of AstraZeneca's Investigational Oral Anticoagulant EXANTA(R) (ximelagatran) Following Total Knee Replacement (TKR) Surgery
08:08 ET	Phase III Study Reports the Results of AstraZeneca's Investigational Oral Anticoagulant EXANTA(R) (ximelagatran) Following Total Knee Replacement (TKR) Surgery
Dec 05, 03
08:01 ET	Survival Analysis Supports Use of FASLODEX as an Effective Option for Metastatic Breast Cancer
Dec 03, 03
10:11 ET	New Data Presented Evaluating Breast Cancer Recurrence Rate in Women Switched From Adjuvant Tamoxifen to ARIMIDEX
Nov 20, 03
18:43 ET	Lancet Publishes Results of Largest Stroke Prevention Trial; AstraZeneca's Investigational Oral Anticoagulant Studied as Alternative to Well-Controlled Warfarin for Stroke Prevention in Atrial Fibrillation
Oct 30, 03
08:05 ET	AstraZeneca Receives Approvable Letter for SEROQUEL(R) (quetiapine fumarate) Tablets in Treatment of Mania
Oct 29, 03
17:02 ET	Two Studies Published in the NEJM Report Effects of AstraZeneca's Investigational Oral Anticoagulant EXANTA(TM) (ximelagatran) on Reducing Risk of Blood Clots
Oct 24, 03
09:05 ET	AstraZeneca Named 'Top Employer' by Science Magazine for Second Straight Year
Oct 23, 03
08:35 ET	AstraZeneca Expands R&D Presence in Boston Area With Focus on Cancer and Infectious Disease
Oct 22, 03
09:24 ET	Award Recognizes Outstanding Representatives in the Field of Breast Cancer Across the Nation
Oct 21, 03
15:48 ET	Pivotal Data on New Lung Cancer Drug IRESSA(R) (gefitinib) Published in The Journal of the American Medical Association
14:41 ET	AstraZeneca Names 2003 `Excellence in Chemistry' Award Winners
Sep 29, 03
13:00 ET	Team up for America's Walk for Diabetes, Sponsored by the American Diabetes Association!
Sep 24, 03
10:05 ET	AstraZeneca Honored as Med Ad News' `Company of the Year'
Sep 23, 03
09:14 ET	AstraZeneca Named Among '100 Best Companies' for Second Year
Sep 10, 03
13:16 ET	AstraZeneca Celebrates 25 Years of Patient Assistance, Company Recognizes Delaware Community Health Professionals
Aug 28, 03
09:00 ET	AstraZeneca Files Second Suit Against KV Pharmaceuticals for Patent Infringement
Aug 22, 03
10:43 ET	Court Decides Formulation Patent for AstraZeneca's Plendil is Valid and Infringed by Mutual Pharmaceutical Co., Inc.
Aug 14, 03
14:28 ET	New IRESSA(R) (gefitinib) Data Presented at World Conference on Lung Cancer
Aug 12, 03
17:37 ET	AstraZeneca's CRESTOR(R) (rosuvastatin calcium) Receives FDA Approval
Aug 08, 03
08:31 ET	AstraZeneca to Seek Treble Damages in Patent Infringement Lawsuit Against Mylan Pharmaceuticals
Aug 06, 03
09:00 ET	New Clinical Trial of FASLODEX(R) (Fulvestrant) Seeks to Identify Additional Therapy Sequence Options for Postmenopausal Women With Metastatic Breast Cancer
Jul 14, 03
09:04 ET	AstraZeneca Reports on Anti-Vascular Approaches to Treat Cancer
Jul 09, 03
16:10 ET	FDA Advisory Committee Unanimously Recommends Approval of CRESTOR(R) (rosuvastatin calcium)
Jun 20, 03
13:52 ET	AstraZeneca Statement Following ZOLADEX Settlement Announcement
13:50 ET	AstraZeneca Announces Settlement With U.S. Government on Zoladex Investigation
May 30, 03
13:10 ET	AstraZeneca Celebrates 25 Years of Oncology Leadership in the U.S.
May 29, 03
13:05 ET	New IRESSA(R) (gefitinib) Data to Be Presented at Annual American Society Of Clinical Oncology Meeting
May 28, 03
08:01 ET	Trials Underway to Evaluate ARIMIDEX in Postmenopausal Women at High-Risk For Developing Breast Cancer and Patients With Very Early Breast Cancer
May 19, 03
16:31 ET	AstraZeneca Confirms Advisory Committee for CRESTOR(R)
May 16, 03
14:34 ET	U.S. Court Dismisses Antitrust Lawsuits Against AstraZeneca
May 12, 03
08:02 ET	ASCO Working Group Assesses Updated Trial Results on ARIMIDEX (R) (Anastrozole) Use for Early Breast Cancer
May 06, 03
17:46 ET	AstraZeneca Files Suit Against KV Pharmaceuticals for Patent Infringement
May 05, 03
12:21 ET	AstraZeneca Receives FDA Approval for New Cancer Drug IRESSA(R) (gefitinib)
Apr 30, 03
10:52 ET	AstraZeneca Issues Correction Regarding Filing of Lawsuit
10:07 ET	AstraZeneca PLC First Quarter Results 2003
Apr 24, 03
13:50 ET	FASLODEX(R) (Fulvestrant) Added to Nationally Recognized Breast Cancer Treatment Guidelines
Apr 22, 03
09:52 ET	AstraZeneca Names Catherine Bonuccelli, MD, Vice President, External Scientific Affairs
Mar 24, 03
09:02 ET	AstraZeneca to Optimize Use of Agency-Related Services Through Consolidation Of Creative Services Assignments
Jan 09, 03
10:05 ET	AstraZeneca Announces FDA Requires More Time for Priority Review of IRESSA(R) (ZD1839) U.S. Application - Decision Expected by May 5th